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Abstract 
This study investigates and interrogates the impact of various marketing strategies on the 
sales of major multinational pharmaceutical companies in Pakistan; include Abbott, GSK 
and Aventis, while applying the censored regression. Besides interrogating the possible 
impacts of various marketing strategies which include the Promotional Gifts, Sponsored 
Trips, Differentiated Strategy, Un Differentiated Strategy, Product Development and 
Establishing the Brand, on the sales of outlined pharmaceutical MNCs, Objectively this 
study also focuses on the applications of Scaled OLS model (censored regression) in 
comparisons with the ordinary least square model. The findings reveal that, all of the 
outlined strategies do matter to the sales of stated MNCs but promotional gifts and 
sponsored trips they really work much than the rest of strategies considered, in long run 
only for Abbott Pakistan, while the differentiated and un-differentiated strategies for 
GSK and product development and establishing the brands for Aventis are revealed as the 
best most options for maximizing sales. Whereas, it is also found that the scaled OLS 
(censored regression) is the better and robust model in investigating the manifested 
proposition than the MLR. 
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1. Introduction 
Pharmaceutical industry is considered to be the world’s biggest industry and due to new demands form 
providers, manufactures and payers there have been major changes in these few years in Pharma industry. 
Similar to other industries, customers demand the same kind of convenience and choice form the Pharma 
industry as well. Number of pharmaceutical companies has been successful in planting various strategies 
to target and attract various types of customer, but due to dynamic nature of customers and business trends 
there are new opportunities and challenges that are to be tackled. There is a complex link between the 
healthcare and pharmaceutical industry. A physician prescriptions although have a direct impact on the 
sales of pharma products, but ultimately the patients are the ones who have to pay and bear the cost in 
terms of both health and money if prescriptions are just revenue oriented (Agarwal, Desai, Holcomb, & 
Oberoi, 2001). 
 The main constituent of the marketing strategy that are used for the marketing of the drugs to the 
physicians are Pharmaceutical representatives (medical representatives), while, the revenues which are 
generated from the annual productions of the pharmaceutical sector involves an amount of about 15 to 20 
% as an expense which are incurred for the sales force and in implementing various sales and marketing 
strategies on average (Agarwal, Desai, Holcomb, & Oberoi, 2001). The cost of implementing various 
sales and marketing strategies heavily overburdened due the overwhelming sponsored trips of practioners 
on the expense of firms operating in the pharma industry. But for quite several times the various firms 
specifically MNCs enjoy the substantial portion of market share due to such strategy. 
 This paper is an attempt to gauge the contributions of promotional gifts and sponsored trips to 
medical doctor as the marketing strategies in enhancing the sales of Pharmaceutical products in 
comparison with the various other outlined marketing strategies which include differentiated strategy, 
undifferentiated strategy, product development, and establishing brands. 
 
2. Literature Review 
There are four traditional strategic P’s (product, price, place and promotion) and three extensions strategic 
P’s (people, process and physical evidence). In strategic marketing the traditional P’s are used for Goods 
and extensions are in Services. To manage these P’s marketers use four strategic C’s (customer solution, 
customer cost, convenience and communication). Strategic marketing is a holistic marketing concept 
where four P’s and four C’s are integrated. It focuses on customer, core competencies and collaborative 
network. Strategic marketing is a long term and pre-nurtured plan for contingency process (Blumberg & 
Perrone, 2001).  
 Marketing strategy is the best fit of the organizational resources and strategies and the 
opportunities of growth in the marketplace. Marketing strategy maintains the profitability and strength of 
the products in the market; it maintains the standard and also shapes the organization. Four P’s are the 
tools for playing the marketing game which results in satisfaction for the customers and thus increases 
customer loyalty and profitability (Subhash, 2009). Various literature confirm that various marketing 
strategies are used by the all national and multinational pharmaceutical firms, which include differentiated 
strategy, undifferentiated strategy, product development, establishing the brands (Baker & Lutz, 2000), 
along with the promotional gifts, sponsored trips. Subhash (2009) confirms that out of all various 
strategies, the promotional gifts and sponsored trips are found enormously fruitful in shooting the sales of 
pharma products in Pakistan. Aaker, Batra, andMyers (1992) also confirm, customer psyche as an 
important player in enhancing sales for health related products specifically, Aaker, Batra, and Myers 
(1992) further stressed that consumers of health related products if they are the medical doctors always 
react to the incentives which are offered in terms of promotional gifts to them and they actually make up 
their minds and decide when they are in a stage between getting a stimulus and reacting according to it. 
Marketers make an effort to identify the group of physicians that are expected to recommend a particular 
drug. Traditionally, it was done through taking into account the total prescriptions (TRx) and new 
prescriptions (NRx) written by every physician each week. The commercial traders then gather this data 
and depending on the pattern of prescription writing by the physicians, they are "deciled" in ten groups. 
Those physicians who fall in higher deciles are contacted more vigorously and the gifts and tours kinds of 
incentives are offered to them only (Scherer, Harhoff, & Kukies, 2000).  Bagozzi (1988) has presented an 
updated theory of perception that the consumers show their interest where they are coordinated and 
interacted. Rust (1997) confirms that the input and output of business should be equal to the input and 
output of buyers interest towards that business. Buyers indeed are important for making sales for the item, 
and hence they are supposed to be satisfied.  Fornell (2002) stated that the overall sales portion in a 
business is based upon a strong relationship with customers, which makes the way for organizations to 
formulate its various marketing strategies. Besides offering gifts to consumers (medical doctors) the 
pharmaceutical companies of both nationals and multinationals nature also mix and match the blend of 
modern and traditional strategies such as Corner and Hinton (2002) found undifferentiated strategy to 
enhance the sales in relations to the mass market for pharmaceutical products. Maynard (1995) found 
product development to modify or update organization’s existing brand or adding a new product in the 
existing product line and to approach the sales target. On the other hand Gurău (2005) convinced that 
establishing the brand plays a pivot role in generating lucrative business in pharama. Fjermestad & 
Romano (2004) ranked Innovative strategy the best most strategy in achieving the target sales among 
multinational pharmaceutical firms. 
3. Research Method 
 
3.1 Descriptions of Data and Sampling Method 
To investigate the application of censored regression when various marketing strategies effects the sales of 
pharmaceutical industry, non parametric data of various proxies of marketing strategies which include 
Promotional Gifts, Sponsored Trips, Differentiated Strategy, Un Differentiated Strategy, Product 
Development, Establishing The Brand, have been collected through using the unrestricted non-probability 
sampling. 300 responses for the outlined proxies/ constructs from the various product and marketing 
managers of all major multinational pharmaceutical firms (i.e. Abbott, GSK,  and Aventis) have been 
interrogated to conclude the findings. 
 
3.2 Econometrical Methodology 
As mentioned already that the censored regression has been employed to investigate and confirm the 
impact and effect of outlined various marketing strategies on the sales of pharmaceutical industry. The 
log-likelihood for the censored regression model can be explained as: 
ln  =   − 12 
log2 + ln  +
 − x′   
+   
1 − Φ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 The log likelihood is a nonstandard type, since it is a mixture of discrete and continuous 
distributions. But Amemiya (1973) confirmed that, despite the complications, proceeding in the usual 
fashion to maximize log L would generate an estimator with all the familiar desirable properties attained 
by MLEs. The log-likelihood function is rationally involved when the data is censorable, but Olsen’s 
(1978) re-parameterization fairly explains the simplifications of censored regression. When, ! = / and # = 1/, the log-likelihood is  
ln  =   − 12 $ln 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4. Findings and Results      
There are several constructs which effect and explain the increase in sales of pharmaceutical MNCs. This 
study is an attempt to interrogate and confirm the effects of various outlined marketing strategies on the 
sales of MNCs of pharmaceutical industry, when censored regression is used the gauge the propositions. 
As revealed in table 1, that Scaled OLS model (Censored regression/ Tobit model) is a better and robust 
model in comparisons of Multiple linear regression (OLS) in explaining the effects of various outlined 
marketing strategies on MNCs sales, include the sales of Abbott, GSK and Aventis, as the for all outlined 
MNCs the Adj. R squared and their respective F statistics for scaled OLS/ tobit model are found huskier 
than the OLS/ MLR.  
In table 1 the findings of Tobit model also show that the marketing strategies which include promotional 
gifts and sponsored trips are the most effective contributors in enhancing the sales of Abbott Pakistan then 
the all rest of the strategies Abbott deploys (as beta= 132.23 at t= 13.54 for predictor= promotional gifts; 
beta= 32.07 at t= 3.96 for predictor= sponsored trips). 
 
Table 1: Censored Regression (Tobit) Estimates of Sales Equation in comparison of OLS Estimates. 
PREDICTORS 
ABBOTT 
 
GSK 
 
AVENTIS 
 
Scaled OLS 
(Tobit) 
Coefficients 
OLS 
Beta 
Scaled OLS 
(Tobit) 
Coefficients 
OLS 
Beta 
Scaled OLS 
(Tobit) 
Coefficients  
OLS 
Beta 
Constant  
1123.54 235 984.03 217 876.05 -46.87 
(24.99) (0.99) (9.68) (0.63) (8.08) (-4.01) 
Promotional 
Gifts 
132.23 17.02 123.45 111.11 56.12 34.43 
(13.54) (3.91) (11.14) (6.06) (3.97) (1.50) 
Sponsored 
Trips 
32.07 20.78 22.59 17.29 29.66 4.99 
(3.96) (2.88) (4.73) (0.82) (4.01) (0.90) 
Differentiated 
Strategy 
45.65 21.23 86.39 7.98 79.03 0.09 
(6.66) (4.73) (10.07) (2.19) (9.65) (2.94) 
Undifferentiated 
Strategy 
15.48 1.17 21.83 1.24 17.23 0.41 
(3.87) (0.92) (5.31) (2.05) (6.43) (1.72) 
Product 
Development 
117.23 0.08 76.76 5.22 156.82 43.00 
(15.25) (1.32) (3.88) (1.55) (16.77) (1.78) 
Establishing The 
Brand 
7.08 4.00 14.09 0.03 31.13 15.70 
(5.67) (0.95) (7.11) (1.61) (4.09) (2.03) 
 Adj. R Squared 0.79 0.11 0.83 0.51 0.69 0.49 
F- Statistics 2354.02 12.07 1019.99 342.03 596.98 222.72 
Sample size 1000 1000 1000 
 
 While, both the differentiated and un-differentiated strategies are more effective players in 
increasing the sales of GSK (as beta= 86.39 at t= 10.07 for predictor= differentiated strategy; beta= 21.83 
at t= 5.31 for predictor= un-differentiated strategy) and for Aventis the product development and 
establishing new brands are the better tools and strategic options in maximizing the sales (as beta= 156.82 
at t= 16.77 for predictor= product development; beta= 31.13 at t= 4.09 for predictor= establishing new 
brands). It is also note able in the findings that the players which are so to speak as the most effective 
contributors for increasing the sales of theses outlined MNCs, as revealed by Tobit model are found have 
the long term associations with the revenue generations for these MNCs. 
 
5. Discussion and Conclusion 
In pharmaceutical industry the end users are not the ultimate buyers as consumer is not in the direct 
contact with the salesman. Here doctors or medical practitioners act as a customer and decide what 
medicine should be consumed in what quantity and for how long that medicine should be continued. 
Indeed, there are various factors which influence consumers’/ customers’ behaviors. And out of various 
factors firms also formulate and deploy their tested strategies to win the market share and to maximize 
sales. This paper is an attempt to enumerate some of those strategies as outlined and their affect and 
impact in explaining and contributing the MNCs sales in Pakistan. Categorically it was found that 
different MNC has the different key factors and deployed strategies while going for to compete in market 
with competitors. Results revealed that the all outlined MNCs though working in the same cultural 
environment and surrounded by the same psychographic constraints but they all have non-identical 
strategies to get the identical goals.  It has also been concluded that censored regression/ Tobit model is 
found as a comparative robust model in gauging the propositions. 
 
6. Policy Implications 
This paper is a point to ponder for the marketers of all non performing local and MNCs of pharmaceutical 
industry to revisit to their deployed strategies. The firms similar to Abbott should confirm Abbott’s 
strategies (as revealed in this paper) in their marketing ventures to maximize the sales. Similarly the firms 
similar to GSK and Aventis should opt those strategic options which are found successful for these two 
MNCs while trying to enhance their sales. This paper is also a point to ponder for Abbott that this MNC 
never endeavored to deploy other strategic options in their marketing ventures except of deploying second 
rate options which include promotional gifts and sponsored trips for medical doctors/ physicians in order 
to win their medical prescriptions for patients.  
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